Cabot (NYSE:CBT) Issues Quarterly Earnings Results

Cabot (NYSE:CBT) issued its quarterly earnings results on Monday. The specialty chemicals company reported $1.80 EPS for the quarter, missing the consensus estimate of $1.81 by ($0.01), Briefing.com reports. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $1.01 billion. During the same period last year, the firm earned $1.65 earnings per share. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Stock Down 1.1 %

Shares of CBT opened at $108.88 on Wednesday. Cabot has a 52 week low of $66.02 and a 52 week high of $117.14. The firm has a market cap of $5.97 billion, a P/E ratio of 12.95, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. The firm’s 50-day simple moving average is $108.41 and its 200 day simple moving average is $101.13. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22.

Analysts Set New Price Targets

Several equities research analysts have commented on CBT shares. JPMorgan Chase & Co. boosted their price target on shares of Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. UBS Group lowered their price objective on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 6th. Finally, Mizuho boosted their price objective on shares of Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a research note on Tuesday. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $105.00.

Insider Activity at Cabot

In related news, EVP Hobart Kalkstein sold 5,457 shares of the company’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total value of $548,865.06. Following the transaction, the executive vice president now owns 61,688 shares in the company, valued at approximately $6,204,579.04. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Jeff Ji Zhu sold 1,201 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $106.19, for a total transaction of $127,534.19. Following the sale, the executive vice president now directly owns 96,000 shares of the company’s stock, valued at approximately $10,194,240. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Hobart Kalkstein sold 5,457 shares of the business’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total value of $548,865.06. Following the completion of the transaction, the executive vice president now directly owns 61,688 shares of the company’s stock, valued at approximately $6,204,579.04. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,665 shares of company stock worth $4,986,299. Insiders own 3.07% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.